CytomX Therapeutics (CTMX) Earnings (2014 - 2026)
CytomX Therapeutics (CTMX) earnings from Sep 30, 2014 to Mar 31, 2026. The TTM CytomX Therapeutics (CTMX) earnings is -$35M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
CytomX Therapeutics (CTMX) Earnings CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -5.84% |
| 5 Years TTM | -0.55% |
| 10 Years TTM | +2.70% |
| All Time TTM | +8.99% |
Annual Earnings change of CytomX Therapeutics (CTMX)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$18M | +5.07% |
| 2025 | -$17M | -154.50% |
| 2024 | $32M | -5691.23% |
| 2023 | -$570K | -99.43% |
| 2022 | -$99M | -14.28% |
| 2021 | -$116M | +252.40% |
| 2020 | -$33M | -7.25% |
| 2019 | -$35M | -58.10% |
| 2018 | -$85M | +96.29% |
| 2017 | -$43M | -26.83% |
| 2016 | -$59M | +66.53% |
| 2015 | -$35M | +16.69% |
| 2014 | -$30M | +100.20% |
| 2013 | -$15M | N/A |
Comparison CytomX Therapeutics (CTMX) five years earnings CAGR with competitors
CytomX Therapeutics (CTMX) five years earnings CAGR is 1.52%.